Capital flows, scientific infrastructure, and computational dependencies in an industry moving from lab to clinic The longevity sector raised $3.74 billion in the first quarter of 2026 alone, a 56 percent increase over the same period in 2025. That number deserves...
Medical Tech
Sequencing the human genome was the hard part. Turning that data into something useful at scale is where the real infrastructure build-out begins. By Rabbt The Human Genome Project completed its first draft in 2003 and took thirteen years. A modern NovaSeq X...
Medicine has finally crossed the sci-fi line.Cures that once lived in labs are now on the market. Neural interfaces let paralyzed patients move robotic arms. AI predicts cancer years before symptoms. New pain drugs work without addiction. But beneath those headlines...
For a moment, imagine the daily noise of diabetes going quiet. No alarms. No finger sticks. No mental arithmetic every time you eat. That “what if?” has hovered over type 1 diabetes for a century—then, in August 2025, a startling first: a man with long-standing T1D...
Muscle wasting, or atrophy, is a significant concern in aging populations and individuals with chronic illnesses. Recent research has unveiled a protein that plays a crucial role in preventing muscle breakdown, offering promising avenues for longevity technology and...
Picture this: diseases spotted before your body even knows they're coming, prosthetics that feel like they've been plucked straight from a sci-fi epic, and treatments so precise, they'd make the word "generic" feel like ancient history. It's not some out-there fantasy...
This summer, a game-changing force in medical research is set to launch: the University of Bristol's $281 million Isambard-AI supercomputer. More than just a powerful machine, Isambard-AI represents the dawn of a new era in healthcare, where artificial intelligence...